Metabolic acidosis aggravation and hyperkaliemia in hemodialysis patients treated by sevelamer hydrochloride.

Author: IliopoulosAnastasios N, KoutalaKaliopi G, MarioliStamatia I, PaniIoanna T, SonikianMacroui A, VlassopoulosDimosthenis A

Paper Details 
Original Abstract of the Article :
Reports on acid-base side effects of sevelamer hydrochloride (SH), a new aluminum (Al)- and calcium (Ca)-free phosphate binder are rare and conflicting. In a retrospective analysis, we evaluated SH impact on metabolic acidosis and serum potassium (K) in hemodialysis (HD) patients. Two groups of stab...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/15807177

データ提供:米国国立医学図書館(NLM)

Sevelamer Hydrochloride: A Tale of Two Sides in Dialysis

This research explores the use of sevelamer hydrochloride (SH), a medication used to control phosphate levels in hemodialysis patients, and its potential impact on metabolic acidosis and serum potassium levels. It's like navigating a complex desert landscape, where seemingly beneficial interventions can have unexpected consequences.

Unmasking the Hidden Effects of Sevelamer Hydrochloride

The study reveals that long-term use of SH can lead to an aggravation of metabolic acidosis and an increase in serum potassium levels in hemodialysis patients. It's like discovering that a specific plant in the desert, while offering sustenance, can also have unintended consequences on the surrounding ecosystem. This research emphasizes the importance of carefully monitoring patients and adjusting treatment strategies to minimize potential side effects.

Navigating the Complexities of Dialysis Treatment

This research underscores the complexity of dialysis treatment, where the benefits of one medication can be intertwined with potential risks. It's like navigating a desert where finding water can also lead to encountering unexpected challenges. Careful monitoring and individualized treatment approaches are crucial in ensuring the best possible outcomes for hemodialysis patients.

Dr.Camel's Conclusion

Sevelamer hydrochloride is a valuable tool in managing phosphate levels in hemodialysis patients, but it's crucial to be aware of its potential side effects. Just as a desert traveler must be prepared for unexpected obstacles, healthcare providers must monitor patients closely and adjust treatment strategies as needed to minimize any negative consequences. This research emphasizes the importance of continuous learning and adaptation in the field of dialysis care.

Date :
  1. Date Completed 2005-06-09
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

15807177

DOI: Digital Object Identifier

15807177

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.